Checkpoint Therapeutics, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$0.27 | -$0.27 | -$0.27 |
Q2 2024 | 0 | -$0.31 | -$0.31 | -$0.31 |
Q3 2024 | 2 | -$0.15 | -$0.15 | -$0.15 |
Q4 2024 | 0 | -$0.16 | -$0.16 | -$0.16 |
Q1 2025 | 1 | -$0.11 | -$0.11 | -$0.11 |
Q2 2025 | 1 | $0.06 | $0.06 | $0.06 |
Q3 2025 | 1 | $0.13 | $0.13 | $0.13 |
Q4 2025 | 1 | $0.13 | $0.13 | $0.13 |
Checkpoint Therapeutics, Inc. Earnings Date And Information
Checkpoint Therapeutics, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $-0.18 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.11. The company had revenue of 41,000 for the quarter and had revenue of 103,000 for the year. Checkpoint Therapeutics, Inc. has generated $-3 earnings per share over the last year ($-2.77 diluted earnings per share) and currently has a price-to-earnings ratio of -1.93. Checkpoint Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based on prior year's report dates.
Checkpoint Therapeutics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/12/2024 | Q2 2024 | -$0.29 | -$0.18 | 0.11 | $15,500 | $41,000 |
05/10/2024 | Q1 2024 | -$0.37 | -$0.33 | 0.04 | $0 | |
03/22/2024 | Q4 2023 | -$0.74 | -$0.70 | 0.04 | $6,000 | |
11/13/2023 | Q3 2023 | -$0.85 | -$0.29 | 0.56 | $16,667 | $31,000 |
08/14/2023 | Q2 2023 | -$0.83 | -$1.05 | -0.22 | $5,000 | $31,000 |
05/15/2023 | Q1 2023 | -$0.92 | -$0.24 | 0.68 | $35,000 | |
03/31/2023 | Q4 2022 | -$2.47 | $74,000 | |||
11/10/2022 | Q3 2022 | -$1.19 | $23,333 | $48,000 | ||
08/12/2022 | Q2 2022 | -$1.70 | -$1.61 | 0.09 | $17,500 | $18,000 |
05/12/2022 | Q1 2022 | -$1.10 | -$1.98 | -0.88 | $52,000 | |
03/28/2022 | Q4 2021 | -$3.79 | $16,000 | |||
11/04/2021 | Q3 2021 | -$1.30 | -$1.43 | -0.13 | $114,000 | $29,000 |
08/06/2021 | Q2 2021 | -$1.21 | $114,000 | $155,000 | ||
05/07/2021 | Q1 2021 | -$0.93 | $68,000 | |||
03/12/2021 | Q4 2020 | -$1.81 | $27,000 | |||
11/06/2020 | Q3 2020 | -$0.87 | $193,333 | $28,000 | ||
08/06/2020 | Q2 2020 | -$0.90 | $393,333 | $42,000 | ||
05/07/2020 | Q1 2020 | -$0.64 | $972,000 | |||
03/11/2020 | Q4 2019 | -$1.73 | $25,000 | |||
11/08/2019 | Q3 2019 | -$1.51 | $566,667 | $280,000 |
Checkpoint Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Checkpoint Therapeutics, Inc.'s earnings date?
Checkpoint Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Sunday, November 10th, 2024 based off last year's report dates.
-
Did Checkpoint Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Checkpoint Therapeutics, Inc. (:CKPT) reported $-0.18 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.11.
-
How can I listen to Checkpoint Therapeutics, Inc.'s earnings conference call?
The conference call for Checkpoint Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Checkpoint Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Checkpoint Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Checkpoint Therapeutics, Inc. generate each year?
Checkpoint Therapeutics, Inc. (:CKPT) has a recorded annual revenue of $103,000.
-
How much profit does Checkpoint Therapeutics, Inc. generate each year?
Checkpoint Therapeutics, Inc. (:CKPT) has a recorded net income of $103,000. Checkpoint Therapeutics, Inc. has generated $-2.77 earnings per share over the last four quarters.
-
What is Checkpoint Therapeutics, Inc.'s price-to-earnings ratio?
Checkpoint Therapeutics, Inc. (:CKPT) has a price-to-earnings ratio of -1.93 and price/earnings-to-growth ratio is -0.03.